Abivax S.A.
AAVXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 133.5% | 0.8% | 12,286.5% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 97.2% | 98.5% | -321.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,592.7% | -2,882.6% | -1,163.3% | -104,697.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,633.1% | -3,197.1% | -1,524% | -111,775.7% |
| EPS Diluted | -2.8 | -3.43 | -3.13 | -2.47 |
| % Growth | 18.4% | -9.6% | -26.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |